Lance Wilkes
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
24
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lance Wilkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Outperform | $96 → $88 | $63.52 | +38.54% | 4 | Oct 30, 2024 | |
| HUM Humana | Upgrades: Outperform | $308 | $260.71 | +18.14% | 3 | Oct 8, 2024 | |
| HCA HCA Healthcare | Downgrades: Market Perform | $301 | $357.19 | -15.73% | 4 | Jan 4, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $372 | $316.49 | +17.54% | 6 | Jan 4, 2024 | |
| UNH UnitedHealth Group | Upgrades: Outperform | $595 → $603 | $567.56 | +6.24% | 4 | Jul 18, 2023 | |
| CVS CVS Health | Maintains: Market Perform | $107 → $93 | $55.81 | +66.64% | 3 | May 2, 2023 |
Centene
Oct 30, 2024
Maintains: Outperform
Price Target: $96 → $88
Current: $63.52
Upside: +38.54%
Humana
Oct 8, 2024
Upgrades: Outperform
Price Target: $308
Current: $260.71
Upside: +18.14%
HCA Healthcare
Jan 4, 2024
Downgrades: Market Perform
Price Target: $301
Current: $357.19
Upside: -15.73%
The Cigna Group
Jan 4, 2024
Upgrades: Outperform
Price Target: $372
Current: $316.49
Upside: +17.54%
UnitedHealth Group
Jul 18, 2023
Upgrades: Outperform
Price Target: $595 → $603
Current: $567.56
Upside: +6.24%
CVS Health
May 2, 2023
Maintains: Market Perform
Price Target: $107 → $93
Current: $55.81
Upside: +66.64%